Cumberland Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.76M | Sell |
125,311
-33
| -0% | -$2.31K | 0.61% | 36 |
|
|
2025
Q1 | $9.21M | Buy |
125,344
+120,733
| +2,618% | +$8.87M | 0.71% | 32 |
|
|
2024
Q4 | $302K | Buy |
4,611
+213
| +5% | +$14K | 0.02% | 155 |
|
|
2024
Q3 | $343K | Buy |
4,398
+233
| +6% | +$18.2K | 0.02% | 166 |
|
|
2024
Q2 | $325K | Sell |
4,165
-1,245
| -23% | -$97.1K | 0.02% | 161 |
|
|
2024
Q1 | $367K | Buy |
5,410
+65
| +1% | +$4.4K | 0.03% | 177 |
|
|
2023
Q4 | $362K | Hold |
5,345
| – | – | 0.03% | 165 |
|
|
2023
Q3 | $362K | Hold |
5,345
| – | – | 0.03% | 157 |
|
|
2023
Q2 | $383K | Sell |
5,345
-100
| -2% | -$7.16K | 0.04% | 144 |
|
|
2023
Q1 | $378K | Hold |
5,445
| – | – | 0.04% | 147 |
|
|
2022
Q4 | $369K | Sell |
5,445
-1,150
| -17% | -$78K | 0.04% | 147 |
|
|
2022
Q3 | $362K | Hold |
6,595
| – | – | 0.04% | 138 |
|
|
2022
Q2 | $436K | Buy |
+6,595
| New | +$436K | 0.04% | 140 |
|